u/DisastrousYouth8629

Diabetes can silently damage the kidneys long before obvious symptoms appear. By the time traditional indicators show significant decline, patients may already be facing advanced kidney risk.
DNlite-IVD103 is a non-invasive urine-based test developed to support early assessment of diabetic kidney disease progression. By detecting urinary post-translationally modified Fetuin-A, DNlite-IVD103 provides clinicians with additional insight beyond conventional kidney markers such as eGFR and UACR.
With only a simple urine sample, DNlite-IVD103 helps identify diabetic patients who may require closer monitoring, earlier clinical intervention, and more personalized care.
Why DNlite-IVD103?
• Simple urine sample
• Early risk insight for diabetic kidney disease
• Complements standard kidney function tests
• Supports preventive and personalized care
• Designed for diabetes clinics, nephrology centers, laboratories, and health screening programs
Kidney disease prevention starts with better risk detection.
DNlite-IVD103 helps bring diabetic kidney disease management one step earlier.